162 related articles for article (PubMed ID: 35077462)
21. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
Cheng P; Ma J; Zheng X; Zhou C; Chen X
Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
[TBL] [Abstract][Full Text] [Related]
22. Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.
Capriglione S; Plotti F; Miranda A; Ricciardi R; Scaletta G; Aloisi A; Guzzo F; Montera R; Angioli R
Tumour Biol; 2015 Jun; 36(6):4151-6. PubMed ID: 25577252
[TBL] [Abstract][Full Text] [Related]
23. Aberrant TRPC1 expression reflects stromal cervical invasion, lymphovascular invasion, elevated FIGO stage, and poor survival in resectable endometrial carcinoma patients.
Wang Y; Zhang C
J Clin Lab Anal; 2022 Aug; 36(8):e24560. PubMed ID: 35754147
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
[TBL] [Abstract][Full Text] [Related]
25. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical Detection of Hematopoietic Cell-specific Protein-Tyrosine Phosphatase (Tyrosine Phosphatase SHP-1) in a Series of Endometrioid and Serous Endometrial Carcinoma.
Giordano G; Campanini N; Goldoni M; Rodolfi AM; Brigati F; Merisio C; Berretta R
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):468-477. PubMed ID: 28187032
[TBL] [Abstract][Full Text] [Related]
27. LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.
Kim SI; Lee JW; Lee N; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
BMC Cancer; 2018 May; 18(1):494. PubMed ID: 29716549
[TBL] [Abstract][Full Text] [Related]
28. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis.
Zhang Y; Zhang W; Li X; Li D; Zhang X; Yin Y; Deng X; Sheng X
Arch Gynecol Obstet; 2016 Jun; 293(6):1287-95. PubMed ID: 26437953
[TBL] [Abstract][Full Text] [Related]
30. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
[TBL] [Abstract][Full Text] [Related]
31. BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.
Liu J; Tian T; Liu X; Cui Z
J Immunol Res; 2022; 2022():6051092. PubMed ID: 35915658
[TBL] [Abstract][Full Text] [Related]
32. Mining of clinical and prognosis related genes in the tumor microenvironment of endometrial cancer: A field synopsis of observational study.
Li W; Qin Y; Chen X; Wang X
Medicine (Baltimore); 2023 Jun; 102(25):e34047. PubMed ID: 37352078
[TBL] [Abstract][Full Text] [Related]
33. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
34. L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
Dellinger TH; Smith DD; Ouyang C; Warden CD; Williams JC; Han ES
Gynecol Oncol; 2016 May; 141(2):336-340. PubMed ID: 26861585
[TBL] [Abstract][Full Text] [Related]
35. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
36. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
Wu X; Han Y; Liu F; Ruan L
J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
[TBL] [Abstract][Full Text] [Related]
37. Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer.
Oshita T; Nagai N; Ohama K
Int J Oncol; 2000 Dec; 17(6):1225-30. PubMed ID: 11078809
[TBL] [Abstract][Full Text] [Related]
38. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome.
Kong Y; Ren Z
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8113-8118. PubMed ID: 30556848
[TBL] [Abstract][Full Text] [Related]
40. PD-1 Coexpression Gene Analysis and the Regulatory Network in Endometrial Cancer Based on Bioinformatics Analysis.
Wang L; Liu Z; Zhang W; Zhang A; Qu P
Biomed Res Int; 2021; 2021():9923434. PubMed ID: 34124265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
